2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @simply_stocks: Starting a separate Biostocks long term portfolio this year . Will add some tickers over next few months . Already have\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'RT @Pharmdca: As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\xe2\x80\xa6'
2021-01-04,b'As of last Thursday: Top Biotech positions I own from 2020 into 2021 and continue to add in following order\n1) $PAVM\n2) $KPTI\n3) $OCUL\n4) $TRIL\n5) $MYOV\n6) $ONCT\n7) $SIOX\n8) $ABUS\n9) $TCON\n10) $PDSB'
2021-01-04,"b'RT @biostonks: If you haven\xe2\x80\x99t joined a cult, you should look into it \xf0\x9f\x98\x82. I am a proud member of the $SGMO $OCUL $MYOV cult'"
2021-01-04,b'Starting a separate Biostocks long term portfolio this year . Will add some tickers over next few months . Already have $PAVM and $MREO . Doing some DD tonight on $TRIL $ONCT $SIOX $XAIR $ONCT $KPTI $AFMD $PDSM $OCUL $ADAP $MMED'
2021-01-04,b'$OCUL $20.70 +0.38  +1.87%OTX-TIC Glaucoma and ocular hypertension Phase 1 top-line data for third and fourth cohorts due mid-2021. Interim update due at a medical conference 1Q 2021. Phase 2 trial to be initiated mid-2021.'
2021-01-03,b'RT @pawcio2009: #Biopick2020 Final Standings. \nWhat a way to finish! $cydy takes the 3rd away from $ocul! Wow. \n\n1. $tril   +1328%\n2. $rvp\xe2\x80\xa6'
2021-01-03,b'RT @SnackBioTech: $PAVM seems a year or two premature here..but I would have said the same thing about $OCUL this time last year. Momentum\xe2\x80\xa6'
2021-01-03,"b'$RMTD Share Price To Rise As Nationwide Exposure Coming With ""CNNMoney"" Segment Next Tuesday\nhttps://t.co/Mv3xmUJu9A\n\n$EYES $CHCR $OCUL $GLBS $YUMA $FRA $ACRE $NID $ETB $AFT $BHBK $VNNHF $EOI $CII $SPPP $BRVVF $EGL $FBM $JEMD'"
2021-01-03,b'$PAVM seems a year or two premature here..but I would have said the same thing about $OCUL this time last year. Momentum can do crazy things to a companies balance sheet if they aren\xe2\x80\x99t afraid to issue shares into strength. https://t.co/nFdyTP54Bu'
2021-01-03,"b'@askwarrenbuffet what your view point on $ocul , $ecor and $abus'"
2021-01-03,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 134'
2021-01-03,"b'$OCUL in Downtrend: its price may drop because broke its higher Bollinger Band on November 24, 2020. View odds for this and other indicators: https://t.co/QBAegb7SYV #OcularTherapeutix #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/vGi4ZczaFi'"
2021-01-03,"b'RT @15minofPham: Titans of 2020 (Min $10, Avg Vol 1M). Imagine if you own just 10 at the end of 2019. $BTBT $NVAX $BLNK $GP $RIOT $CRDF $KI\xe2\x80\xa6'"
2021-01-03,b'\xe2\x97\x86 My PF Update 1/3\n\n\xe3\x80\x901\xe8\xbb\x8d\xe3\x80\x91 $FVRR $SE $TDOC\n\n\xe3\x80\x902\xe8\xbb\x8d\xe3\x80\x91 $GRWG $MGNI $OCUL $PGNY $PLUG $SQ\n\n\xe3\x80\x90\xe6\xa7\x98\xe5\xad\x90\xe8\xa6\x8b\xe3\x80\x91 $BNGO $FCEL $FLGT $LAZR $NIO\n\n\xe3\x80\x90ETF\xe3\x80\x91 $LIT $ICLN $REMX'
2021-01-03,"b'RT @sentivcapital: $OCUL Reason for HCW downgrade....unfortunately for HCW, smart mgmt teams avoid having HCW involved in their offerings.\xe2\x80\xa6'"
2021-01-03,"b'If you haven\xe2\x80\x99t joined a cult, you should look into it \xf0\x9f\x98\x82. I am a proud member of the $SGMO $OCUL $MYOV cult https://t.co/UhkIuuhoKn'"
2021-01-02,"b""RT @TeesFine: $OCUL was $4 in March! Now it's $20 #stocks #stockmarket #stock #Stock2020 #Investor #DRIP #investing #invest #investment #in\xe2\x80\xa6"""
2021-01-02,"b""RT @TeesFine: $OCUL was $4 in March! Now it's $20 #stocks #stockmarket #stock #Stock2020 #Investor #DRIP #investing #invest #investment #in\xe2\x80\xa6"""
2021-01-02,"b""$OCUL was $4 in March! Now it's $20 #stocks #stockmarket #stock #Stock2020 #Investor #DRIP #investing #invest #investment #investors #investments #growthstocks #options #OptionsTrading #stockstobuy #StocksToTrade #stockstowatch #ES_F #Futures #generationalwealth #moneytwitter"""
2021-01-02,"b'RT @topologic_apple: @MoneyTrails9 @ThomasPhilipp6 @TonyorAnthony69 @sunrgu @Jessecdghi Even with better long term cyclosporine treatments,\xe2\x80\xa6'"
2021-01-02,b'RT @topologic_apple: @MoneyTrails9 @ThomasPhilipp6 @TonyorAnthony69 @sunrgu @Jessecdghi Cyclosporines are slow acting and have weak activit\xe2\x80\xa6'
2021-01-02,"b'@MoneyTrails9 @ThomasPhilipp6 @TonyorAnthony69 @sunrgu @Jessecdghi Even with better long term cyclosporine treatments, short term corticosteroids will be used and here $KALA is the only one. $OCUL is more a competitor for restasis/xiidra and most patients dont even benefit from those. $KALA sales will be very good imho.'"
2021-01-02,"b'@MoneyTrails9 @ThomasPhilipp6 @TonyorAnthony69 @sunrgu @Jessecdghi Cyclosporines are slow acting and have weak activity in dry eye (restasis was rejected in EU for lack of efficacy). $OCUL is years away, assuming trials are successful + not even a competitor for $KALA as Eysuvis can be taken in combination with cyclosporine to manage flareups.'"
2021-01-02,"b'RT @15minofPham: Titans of 2020 (Min $10, Avg Vol 1M). Imagine if you own just 10 at the end of 2019. $BTBT $NVAX $BLNK $GP $RIOT $CRDF $KI\xe2\x80\xa6'"
2021-01-02,"b'RT @15minofPham: Titans of 2020 (Min $10, Avg Vol 1M). Imagine if you own just 10 at the end of 2019. $BTBT $NVAX $BLNK $GP $RIOT $CRDF $KI\xe2\x80\xa6'"
2021-01-02,"b'Titans of 2020 (Min $10, Avg Vol 1M). Imagine if you own just 10 at the end of 2019. $BTBT $NVAX $BLNK $GP $RIOT $CRDF $KIRK $TRIL $NIO $MARA $VERI $PLUG $CELH $NLS $GRWG $QS $TSLA $FVRR $FUV $SOL $APPS $RVP $OSTK $ENPH $WKHS $FTCH $JMIA $ALT $PRTS $DQ $CLSK $PTON $MRNA $OCUL https://t.co/Oxtw02k7OM'"
2021-01-02,"b""@sunrgu @ThomasPhilipp6 @Jessecdghi You need to think about 10+ years from now who will dominate the market , down the road  it'll be $ocul without a shadow of a doubt \n\nThats why i think $kala s price has been in a downtrend for quite some time , $kala has the upper hand now but in a few years it will be crushed"""
2021-01-02,"b""@Jessecdghi Maybe big pharma will put there eyes on $ocul to snatch it up rather than $kala  since it's the better investment down the road"""
2021-01-02,b'@ParikPatelCFA @chamath : Happy 2021 and I recently started to follow you both and like what you say. I am  also Gujju and in usa on visa and GC  is way out. I mostly trade longvterm and very little of day trades. Wanted to get your opinion on Ocular  therapeutics $ocul.'
2021-01-02,"b""@SeattleTechie40 Wish I trusted my gut and put more into $OCUL. \n\n$IRTC was a tough one as well. I've followed it for a few years but got too picky on the valuation. Completely missed the boat on their rally. Them's the breaks, I guess"""
2021-01-02,b'RT @Multibagger5: @biostockguru #2021biobuyout $OCUL $60'
2021-01-02,"b""@Jessecdghi $kala  i think the reason why the stock is acting so poorly regardless of all the catalyst's / market price not reflecting the true value of the company is that there might be a new competitor joining the field = $ocul"""
2021-01-02,b'RT @pawcio2009: #Biopick2020 Final Standings. \nWhat a way to finish! $cydy takes the 3rd away from $ocul! Wow. \n\n1. $tril   +1328%\n2. $rvp\xe2\x80\xa6'
2021-01-02,b'$OCUL was analyzed by 6 analysts. The buy consensus is at 93%. So analysts seem to be very confident about $OCUL. https://t.co/7eI3LyVtkC https://t.co/3LwGFjxHMo'
2021-01-02,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 48'
2021-01-02,b'@biostockguru #2021biobuyout $OCUL $60'
2021-01-02,"b""RT @kylewdennis: Another Video Watch List for next week's action! Click here to watch it for FREE: ----&gt; https://t.co/TtOEgR4x5P \n\nStocks m\xe2\x80\xa6"""
2021-01-02,b'Like the tech sector for good returns and lower risk. $ZM $TTD $SE $SNAP and others.\n$CELH  was my money maker in 2020. \n\nThere were big movers in biotech sector as well and I missed some of names: $TRIL $OCUL $PSNL $CYDY $AQB $NTLA $DMYK  etc. https://t.co/e9R5zuuy5F'
2021-01-01,b'Now heading into the year with these. I rarely keep one stock as more than 10% of my portfolio most are around 3%\n$IPOC have a sold call at $20 \n$MYOV won\xe2\x80\x99t sell any next year \n$ACAM swing\n$OCUL \xf0\x9f\xa4\xb7\xe2\x80\x8d\xe2\x99\x82\xef\xb8\x8f \n$GTHX \xf0\x9f\xa4\xb7\xe2\x80\x8d\xe2\x99\x82\xef\xb8\x8f \n$LOAC swing\n$SIOX looking to cut down most &gt;3.5ish\n$FSR never sell \xf0\x9f\x98\x82 https://t.co/331XqcusvE'
2021-01-01,"b'Investing wise, 2020 was a great year for me (+61%). It can be hard keeping up with investments during the school year but I feel like most of my trades were sound. Major winners long were $MYOV $OCUL $VCEL $GTHX $SGMO $PSNL and SPACs $IPOC $LCA $SPCE $DKNG https://t.co/HwrWx2s5LS'"
2021-01-01,b'JMP only giving $OCUL 4 top candidates in pipeline 40% probability of success-  would think what we seen so far at least a couple of those that seems low - exciting new year in store for $OCUL'
2021-01-01,b'@jfais20 Yeah but without the new blood at CEO. The arrival of Antony Mattessich changed the trajectory of this company and that cannot be overstated $OCUL'
2021-01-01,b'RT @mediasentiment: $OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 370'
2021-01-01,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 370'
2021-01-01,"b'$OCUL in Downtrend: its price may drop because broke its higher Bollinger Band on November 24, 2020. View odds for this and other indicators: https://t.co/HblUWlb8kX #OcularTherapeutix #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KJVRha7sRW'"
2021-01-01,b'RT @semodough: $OCUL few catalysts 2021 https://t.co/oBTHgxQBKy'
2021-01-01,b'RT @semodough: $OCUL few catalysts 2021 https://t.co/jqe6OFnXxI https://t.co/oBTHgxQBKy'
2021-01-01,b'RT @pawcio2009: #Biopick2020 Final Standings. \nWhat a way to finish! $cydy takes the 3rd away from $ocul! Wow. \n\n1. $tril   +1328%\n2. $rvp\xe2\x80\xa6'
2021-01-01,b'RT @semodough: $OCUL few catalysts 2021 https://t.co/oBTHgxQBKy'
2021-01-01,b'$OCUL few catalysts 2021 https://t.co/jqe6OFnXxI https://t.co/oBTHgxQBKy'
2021-01-01,"b'Year ending with $ESTC, $SE, $PINS, $SQ, $VRM, $SKLZ, $ROKU, $TDOC, $NET, $NVTA, $FSLY, $ETSY \nBio - $MYOV, $AUPH, $TCON, $OCUL, $KPTI, $SGMO, $MREO, $SIOX. - 2021, Bios would get more allocations in new capital. I see too much pump and dump in tech and SPACs are market spoilers.'"
2021-01-01,"b""Happy new year all. First full year of investing and 85.8% return for the year. I'm not sure it's a good start to investing. It just breeds over confidence and greed. :) \n\nThank you $ocul $psnl $myov $alxn and all the others.\n\nLook forward to 2021 of $ocul $KPTI $KALA and more!"""
2021-01-01,b'Top 15 Pharmaceuticals stocks with market cap over 1 billion today. \n\nhttps://t.co/ZX9PwL80hF\n\n$IMAB $TRIL $PMVP $ALGS $PRAX $STOK $ARVN $GILD $SWAV $GH $UTHR $CYTK $PCRX $OCUL $ABBV\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/OZzJbIJN0m'
2020-12-31,b'Next $OCUL https://t.co/4GMzsXQ242'
2020-12-31,b'RT @pawcio2009: #Biopick2020 Final Standings. \nWhat a way to finish! $cydy takes the 3rd away from $ocul! Wow. \n\n1. $tril   +1328%\n2. $rvp\xe2\x80\xa6'
2020-12-31,b'RT @pawcio2009: #Biopick2020 Final Standings. \nWhat a way to finish! $cydy takes the 3rd away from $ocul! Wow. \n\n1. $tril   +1328%\n2. $rvp\xe2\x80\xa6'
2020-12-31,b'#Biopick2020 Final Standings. \nWhat a way to finish! $cydy takes the 3rd away from $ocul! Wow. \n\n1. $tril   +1328%\n2. $rvp    +616%\n3. $cydy  +439%\n\nIndividual leaders:\n1. @eagleowl716\n2. @aaadhikari\n3. @factorrules\n*tiebreak in effect\n\nFull Standings:\nhttps://t.co/nvQCi8JXaJ'
2020-12-31,"b'Will be starting 2021 with $BB $CRIS $EDIT $KPTI $MYOV $OCUL $SAVA $SRNE $TRIL $WMT  only alphabetical order, not weighting. Good luck folks.'"
2020-12-31,"b""@DavidNohejl You should feel great. 2021 is all about metals &amp; crypto as I've learned biotech isn't my expertise. Found a gem but $BCLI slapped me silly after 300% gains when greed kicked in but holding $AUPH $ONCT $PAVM $XAIR $AXSM $APTO $OCUL in smaller amounts. Lots of lessons learned. HNY"""
2020-12-31,b'RT @buysidebio: Piper has $OCUL at almost $2B in peak cash flow. $ALC did 600M in cash flow this year and is valued at 31B. $OCUL PT raised\xe2\x80\xa6'
2020-12-31,b'@lblegend33 It can be anyone from $OCUL $KPTI and $GBT \xf0\x9f\x98\x83'
2020-12-31,"b'RT @PeterRumble1: $OPGN up another 7% today, steady rampup, we will wake up to 5$, +100% in Jan 2021, expected FDA news soon $SPY $XBI $IBB\xe2\x80\xa6'"
2020-12-31,"b'$HJLI +7%, 12$ target \xf0\x9f\x8e\xaf, strong buy after FDA approval, alerted at 8$ $XBI $IBB $MYOV $BTC $PFE $NVAX $MRNA $OCUL $ONCT $KPTI $SPY https://t.co/yJzoQh0Pyu'"
2020-12-31,"b'$OPGN up another 7% today, steady rampup, we will wake up to 5$, +100% in Jan 2021, expected FDA news soon $SPY $XBI $IBB $MYOV $NVAX $MRNA $OCUL $SIOX $ONCT $SLDB $PAVM $KPTI $ABUS $ACAM https://t.co/4mxZHhDBEo'"
2020-12-31,b'@robertcshea How many times will it mention $OCUL'
2020-12-31,"b""RT @jfais20: $Otic, the $ocul of ear\n\nHow's that for a brief thesis? https://t.co/M9UrH7QyNs"""
2020-12-31,b'RT @letterstoyou24: This is from in house team at Kyowa Kirin. Demonstrates they\xe2\x80\x99re at least thinking about anti-vegf eye drops. Still no a\xe2\x80\xa6'
2020-12-31,"b""@CubbieBears @ioTrader #2021stockcontest cc @ioTrader \n\nCan I change my  TICKER to  $OCUL - I don't want to get kicked out.   OCUL is my final decision."""
2020-12-31,"b""$Otic, the $ocul of ear\n\nHow's that for a brief thesis? https://t.co/M9UrH7QyNs"""
2020-12-31,"b'In the biotech race, not much action, $cydy does not seem too interested catching $ocul for 3rd and $ocul not too interested in giving up 3rd. https://t.co/c09jr87DuQ'"
2020-12-31,b'RT @semodough: Just read JMP report on $OCUL PT 30.Please don\xe2\x80\x99t get hung up on price targets especially with biotechs like $OCUL &amp;pipeline\xe2\x80\xa6'
2020-12-31,b'#technicalanalysis #trading #options #optionstrading #tradingtips #tradingpsychology #stockmarket #trading \nLoving $SQ and $OCUL. In Jan 15 $SQ 220 calls for a move to 238'
2020-12-31,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 194'
2020-12-31,"b""$OCUL, $EOSE &amp; $MGNI are getting into green but backing off but $ASHR can't fall because it is tied to Shanghai &amp; CNH which were up last night. It gives me more diversification benefits. On days when market is down but I am up because of $ASHR, I can buy things that are down"""
2020-12-31,"b'$OCUL in Downtrend: its price may drop because broke its higher Bollinger Band on November 24, 2020. View odds for this and other indicators: https://t.co/CJwjverI0I #OcularTherapeutix #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yVTqnaPIJQ'"
2020-12-31,b'RT @BobMarshall63: FWIW changes in LT account - large positions in order: $TGTX $AXSM $DMTK $IPOC $SGMO $XAIR $BTAI $OCUL $KALA $ONCT $TCON\xe2\x80\xa6'
2020-12-31,"b'RT @pawcio2009: This is it Ladies and Gentlemen, one more day, one last lap, perhaps one final Hail Mary? #biopick2020 concludes tomorrow.\xe2\x80\xa6'"
2020-12-31,b'@semodough @Biomaven Yep but don\xe2\x80\x99t see @Biomaven tweet on $OCUL ? Thx'
2020-12-31,b'RT @BobMarshall63: FWIW changes in LT account - large positions in order: $TGTX $AXSM $DMTK $IPOC $SGMO $XAIR $BTAI $OCUL $KALA $ONCT $TCON\xe2\x80\xa6'
2020-12-31,"b'RT @15minofPham: Wed (12/30/20) weakest final 30-min close (Min $5 &amp; Vol 750K, Opt Min Vol 500 in any strike): $MARA $DMTK $IPOC $OCUL $ROO\xe2\x80\xa6'"
2020-12-31,"b""@egelandd @Investor2b @biostockguru The difficulty I see with $kala is that they don't have quite the same payer dynamics as $ocul and a sales ramp might be considerably more difficult?"""
2020-12-31,"b'Wed (12/30/20) weakest final 30-min close (Min $5 &amp; Vol 750K, Opt Min Vol 500 in any strike): $MARA $DMTK $IPOC $OCUL $ROOT $VXX $BGS $PLAY $SOLO $BCRX $MSTR $TIGR $BILI $DDOG $STNG $TGTX $FEYE $LAC $XL $GOEV $PACB $WPRT $MGI $UNFI $NLS $GDRX $RXT $INO $CGC $WBAI $KTOS $REAL https://t.co/P8m3EhLdDX'"
2020-12-31,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-31,"b'RT @IPODave: I do have some single digit names I have options or common on for 2021 - $TCDA, $ONCT, $CRIS, $PAVM + warrants.  Have others s\xe2\x80\xa6'"
2020-12-31,"b'RT @pawcio2009: This is it Ladies and Gentlemen, one more day, one last lap, perhaps one final Hail Mary? #biopick2020 concludes tomorrow.\xe2\x80\xa6'"
2020-12-31,"b'This is it Ladies and Gentlemen, one more day, one last lap, perhaps one final Hail Mary? #biopick2020 concludes tomorrow. Here is where we stand on the biotech race. Perhaps the only fight is for 3rd between $ocul and $cydy? $fate and $tgtx looks like have too much work to do. https://t.co/fNjkTlyrkX'"
2020-12-31,b'RT @BioStocks: $OCUL PT raised to $30 at JMP Securities'
2020-12-30,b'RT @semodough: Just read JMP report on $OCUL PT 30.Please don\xe2\x80\x99t get hung up on price targets especially with biotechs like $OCUL &amp;pipeline\xe2\x80\xa6'
2020-12-30,b'$OCUL https://t.co/znUHG4tKze'
2020-12-30,"b""@rhomboid1MF @crispfinance I've tried a variation. Beaten down biotechs that have a change in story - a new ceo, new trial results. A new lease on life. \nIt's a common story in those circles and returns can be wild. $ocul I started buying in nov 19, 600% on that small starter. $tril was insane, missed it."""
2020-12-30,"b'$OPGN +14%, steady rampup, we will wake up to 5$, +100% in Jan 2021, expected FDA news soon $SPY $XBI $IBB $MYOV $NVAX $MRNA $OCUL $SIOX $ONCT $SLDB $PAVM $KPTI $ABUS $ACAM'"
2020-12-30,b'RT @semodough: Just read JMP report on $OCUL PT 30.Please don\xe2\x80\x99t get hung up on price targets especially with biotechs like $OCUL &amp;pipeline\xe2\x80\xa6'
2020-12-30,b'RT @ainge_man: $OCUL JMP raised PT from $20 to $30\n\nDextenza on track for potential approval in its first in-office indication in Q4 2021\xe2\x80\xa6'
2020-12-30,b'Agreed \xf0\x9f\x91\x87 $OCUL \xf0\x9f\x92\xaa https://t.co/1UgDXzpseA'
2020-12-30,b'Just read JMP report on $OCUL PT 30.Please don\xe2\x80\x99t get hung up on price targets especially with biotechs like $OCUL &amp;pipeline it has. POS=Probability of success - so arbitrary-As probability goes up so will price target-imho confidence growing in pipeline -PT could easily be 50-100'
2020-12-30,b'@SnackBioTech Sold several short puts on $ocul in 2020. Finally got in mid 7s. Then lost them with covered calls around 14. Lesson learned...don\xe2\x80\x99t put entire position on the table.'
2020-12-30,"b'$ARWR and $OCUL are my strongest performing stocks this year, up 198% and 284% respectively. I do not know much about either of them if I\xe2\x80\x99m being honest. This is how 2020 in biotech has been. $XBI'"
2020-12-30,b'RT @ainge_man: $OCUL JMP raised PT from $20 to $30\n\nDextenza on track for potential approval in its first in-office indication in Q4 2021\xe2\x80\xa6'
2020-12-30,"b'@ainge_man \xf0\x9f\x91\x8c\xf0\x9f\x8f\xbb good report , good work ! \xf0\x9f\x93\x9d\xf0\x9f\x94\x9d\xf0\x9f\x8f\xa6\xf0\x9f\x94\xa5\xf0\x9f\x94\xa5 $OCUL'"
2020-12-30,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-30,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-30,b'hcw shit company downgraded $ocul . JMP 10x better at forecasting- upgrade . - all i\xe2\x80\x99ll say is this company is cheap even after the run it had this year . pt $50 ! i have an overweight position already so i\xe2\x80\x99m not going to added more .'
2020-12-30,"b'I do have some single digit names I have options or common on for 2021 - $TCDA, $ONCT, $CRIS, $PAVM + warrants.  Have others smaller in LT acct but hoping some will perform like $OCUL, $PSNL did for us in 2020.'"
2020-12-30,b'RT @BioStocks: $OCUL PT raised to $30 at JMP Securities'
2020-12-30,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-30,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-30,b'When you buy the dip in $OCUL https://t.co/XjV0XTidZM'
2020-12-30,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-30,"b'RT @jfais20: $OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) cou\xe2\x80\xa6'"
2020-12-30,"b'$OCUL JMP boosts PT to $30, interesting readthrough as approval for allergic conjunctivitis (first \xc2\xa8in-office\xc2\xa8 indication) could benefit dry eye program as well'"
2020-12-30,b'Ocular Therapeutix Price Target Raised to $30 from $20 at JMP Securities $OCUL https://t.co/JSy9NPgmW3'
2020-12-30,b'$OCUL \xf0\x9f\x91\x80\xf0\x9f\x91\x80\xf0\x9f\x91\x80 https://t.co/MlxOvt9wUm'
2020-12-30,b'RT @BioStocks: $OCUL PT raised to $30 at JMP Securities'
2020-12-30,b'RT @theflynews: Ocular Therapeutix price target raised to $30 from $20 at JMP Securities $OCUL https://t.co/kv3JrhVqPn'
2020-12-30,b'$ocul https://t.co/2diYTtMz9g'
2020-12-30,b'RT @BioStocks: $OCUL PT raised to $30 at JMP Securities'
2020-12-30,b'RT @Bios_n_Techs: @semodough $KPTI $MYOV $MREO $ONCT $FGEN $TCON $PAVM $TRIL my top additional favs (apart from $OCUL $TGTX)'
2020-12-30,b'RT @BioStocks: $OCUL PT raised to $30 at JMP Securities'
2020-12-30,"b""$OCUL JMP raised PT from $20 to $30\n\nDextenza on track for potential approval in its first in-office indication in Q4 2021\n\nSales of over $150M at peak penetration for allergic conjunctivitis. Potential approval is key development as it could benefit Ocular's dry eye candidates https://t.co/mxMvqixv3L"""
2020-12-30,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 82'
2020-12-30,b'RT @BioStocks: $OCUL PT raised to $30 at JMP Securities'
2020-12-30,b'$OCUL PT raised to $30 at JMP Securities'
2020-12-30,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 75'
2020-12-30,b'Ocular Therapeutix price target raised to $30 from $20 at JMP Securities $OCUL https://t.co/kv3JrhVqPn'
2020-12-30,b'Ocular Therapeutix price target raised to $30 from $20 at JMP Securities\n$OCUL'
2020-12-30,b'This is from in house team at Kyowa Kirin. Demonstrates they\xe2\x80\x99re at least thinking about anti-vegf eye drops. Still no announcement on tivo trial tho. $AVEO\n\nHard to argue drops wouldn\xe2\x80\x99t compete favorably with all these hot device/delivery plays like $OCUL https://t.co/G6LMvAWUWG'
2020-12-30,"b'$FCX Share Price To Rise As Nationwide Exposure Coming With ""CNNMoney"" Segment Next Tuesday\nhttps://t.co/Mv3xmUJu9A\n\n$EYES $CHCR $OCUL $GLBS $YUMA $FRA $ACRE $NID $ETB $AFT $BHBK $VNNHF $EOI $CII $SPPP $BRVVF $EGL $FBM $JEMD'"
2020-12-30,b'HCW as usual have no clue when it comes to valuing bio stock pipeline worth. $OCUL https://t.co/bnxQ156063'
2020-12-30,"b'RT @kevinjaybe: $OCUL JPM Sec maintains Mkt Outperform, PT 30'"
2020-12-30,"b""RT @JamesEKrause: @XBIObserver @ohmsonite $REGN $OCUL $KOD $RGNX $APLS $ANNX #NVS and more...\n\n&lt;It's really something to see the grand visi\xe2\x80\xa6"""
2020-12-29,b'$OCUL\n\nAdded\nAverage price: 20.08 https://t.co/6pnw8a7qzR'
2020-12-29,b'RT @egelandd: @nalyticsatwork @semodough @tun10 When was the last time Antony bought shares in $ocul ? Mark and has exec team at $kala adde\xe2\x80\xa6'
2020-12-29,"b""@XBIObserver @ohmsonite $REGN $OCUL $KOD $RGNX $APLS $ANNX #NVS and more...\n\n&lt;It's really something to see the grand vision&gt;\n\nWhether the double pun was intended or not, one major learning here was to invest in #ophthalmology companies. I have my eyes wide open."""
2020-12-29,b'@sunrgu @TahoeLK But could be $OCUL the $KALA killer? Disclaimer: I am long $KALA.'
2020-12-29,"b'$OCUL JPM Sec maintains Mkt Outperform, PT 30'"
2020-12-29,b'@Pharmdca Not so much for $OCUL'
2020-12-29,b'Next is $ocul. Original trade thesis was to play data in February but the more I look at pipeline the more I think holding for even 1yr+ would lead to an exceptional trade. Not worrying about the blood bath it\xe2\x80\x99s had the last two days because good position average (2/3)'
2020-12-29,"b'Ok, fly to quality... $OCUL $TGTX $XERS $TCON $ONCT ASAP GREEN \xf0\x9f\xa4\x91\xf0\x9f\xa4\x91\xf0\x9f\xa4\x91\xf0\x9f\x8f\xa6\xf0\x9f\x8f\xa6\xf0\x9f\x8f\xa6\xf0\x9f\x94\xa5\xf0\x9f\x94\xa5\xf0\x9f\x94\xa5\xf0\x9f\xa5\x83'"
2020-12-29,b'@path1finder @patorjk $OTIC I would love to see them dosing higher on OTO-413. \n\nAnyway I don\xe2\x80\x98t think market has realised how big this company + their assets could become. MC under $300m + they have indications like hearing loss + tinnitus which are large unmet problems. The $OCUL of ear. Like u said'
2020-12-29,b'RT @Bio12Rick: @HCWCO $ocul Analyst Yi Chen also put a price target on $eypt of $2.50 (prior to their reverse split).  Does this man have c\xe2\x80\xa6'
2020-12-29,"b'@HCWCO $ocul Analyst Yi Chen also put a price target on $eypt of $2.50 (prior to their reverse split).  Does this man have credibility??? Haha not at all, best to do the opposite.  Post the RSS, Yi\xe2\x80\x99s price target on EYPT is $25.00, what a joke.  Why would anyone listen to $HCWCO'"
2020-12-29,b'Downgrades 12/28\n$APRE\n$CNSP\n$OCUL'
2020-12-28,b'RT @egelandd: @nalyticsatwork @semodough @tun10 When was the last time Antony bought shares in $ocul ? Mark and has exec team at $kala adde\xe2\x80\xa6'
2020-12-28,b'RT @egelandd: @nalyticsatwork @semodough @tun10 Lol- all products are absolute down the road- whatever... I own both $ocul &amp; $kala here &amp; y\xe2\x80\xa6'
2020-12-28,b'@nalyticsatwork @semodough @tun10 When was the last time Antony bought shares in $ocul ? Mark and has exec team at $kala added big in late oct- right before approval in high 7s. Good gauge on near-term upside to me!'
2020-12-28,b'@nalyticsatwork @semodough @tun10 Lol- all products are absolute down the road- whatever... I own both $ocul &amp; $kala here &amp; yet believe that $kala will massively outperform $ocul in next 3-6 mths- ocul already had the giant move- which is why they raised- kala has not- will happen imo- GL to both + all involved!'
2020-12-28,"b'@TheMarkCooke We have names in common, so some fell hard. Techs are ~1/3 of my book. ~1/3 is Biotechs but even my star $OCUL acted like $FSLY or $NET today. $EOSE and Biotechs $ONCT and $PAVMZ did better. China is ~1/3. That subgroup was up ~6%.  So a green day overall.'"
2020-12-28,"b""@Bios_n_Techs $OCUL HCW - if they're not involved with secondary offerings on a stock, they're not really bullish.  Jefferies and Piper lead the recent offering"""
2020-12-28,b'$OCUL - HCW setting to neutral is short sighted IMO. Added 20.3. Recent secondary at 21.5 was oversubscribed.'
2020-12-28,b'$OCUL Bought earlier to existing position.'
2020-12-28,b'@Bios_n_Techs $ocul : good opportunity today to Load up ..'
2020-12-28,b'@lblegend33 Opinion on $ocul?'
2020-12-28,"b'RT @sentivcapital: $OCUL Reason for HCW downgrade....unfortunately for HCW, smart mgmt teams avoid having HCW involved in their offerings.\xe2\x80\xa6'"
2020-12-28,b'$ocul 50 day is $18.63. Will it go that low? hmm'
2020-12-28,"b'RT @buysidebio: No Value for TKI in the model. TIC 30% POS, OTX-CSI 35% POS. OTX-CSI is basically Restasis w/ short term relief plug. Resta\xe2\x80\xa6'"
2020-12-28,b'@SunriseTrader $OCUL'
2020-12-28,"b'REVERSALtoDOWN: $OCUL Ocular Therapeutix, Inc https://t.co/bUripsH8sv \xf0\x9f\x93\x89 \xf0\x9f\x94\x9c TradeIdeas via \xe2\x9f\xb6 https://t.co/ZgCyz4rX3x'"
2020-12-28,"b'@measured_moves With $OCUL at 21 only another 3 to 5 points to drop for the ""inevitable leg down"".'"
2020-12-28,"b'$OCUL nice consolidation ongoing ,, low low low volume . Long &amp; Strong \xf0\x9f\x94\x9d\xf0\x9f\x94\xa5\xf0\x9f\x94\xa5\xf0\x9f\xa5\x82'"
2020-12-28,"b'RT @sentivcapital: $OCUL Reason for HCW downgrade....unfortunately for HCW, smart mgmt teams avoid having HCW involved in their offerings.\xe2\x80\xa6'"
2020-12-28,b'Added a little more $ocul at $21.13'
2020-12-28,b'Taking a tiny bit of my $MYOV and $SGMO profits to add more to $OCUL here.'
2020-12-28,b'$OCUL \nDowngraded by HC Wainwright Buy \xc2\xbb Neutral\nhttps://t.co/pkmNpG6eKU'
2020-12-28,"b'Robot taking a swing here in $OCUL\n\nCheck out my trading tools here, https://t.co/pCxc3qQVZx and use TRADEIDEAS15 for 15% off https://t.co/uHqgp5sxKp'"
2020-12-28,b'$OCUL bought at 22.05'
2020-12-28,b'$OCUL: Got back into this this@morning.Don\xe2\x80\x99t want to miss this opportunity.This will go a lot higher!'
2020-12-28,b'added to $OCUL'
2020-12-28,"b'RT @buysidebio: No Value for TKI in the model. TIC 30% POS, OTX-CSI 35% POS. OTX-CSI is basically Restasis w/ short term relief plug. Resta\xe2\x80\xa6'"
2020-12-28,"b'RT @buysidebio: No Value for TKI in the model. TIC 30% POS, OTX-CSI 35% POS. OTX-CSI is basically Restasis w/ short term relief plug. Resta\xe2\x80\xa6'"
2020-12-28,b'$OCUL Ocular TherapeutixTM Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares https://t.co/ULTlBRwfo3'
2020-12-28,b'Picked up some $ocul for the Roth 21.24.'
2020-12-28,"b'No Value for TKI in the model. TIC 30% POS, OTX-CSI 35% POS. OTX-CSI is basically Restasis w/ short term relief plug. Restasis 1B+ rev.  Imagine what their model would show if they had realistic values? I bet HCW adds TKI to model in coming months off 600 dose data.  $OCUL https://t.co/SjhF2cF3Qj'"
2020-12-28,b'@jfigueredo @sentivcapital HCW is the last  company you want covering a bio. They have self interest only perspective. $OCUL wins not having them involved.'
2020-12-28,b'$ALGM $AMAT $AMD $AMST $AVGO $MCHP $LRCX $MU $NXPI $OCUL $ON $PAE $PAYX $POWI $QCOM $QRVO $RUN $STX $WDC $ALV $STZ \nLatest Analyst Reports\nhttps://t.co/Yt5zha1mH9'
2020-12-28,"b'$OCUL \n\nThese words are too true, unfortunately.\n\nBe careful with HCW, folks -- especially as lead underwriter: https://t.co/uiXAeYQqxt'"
2020-12-28,"b""@CHItraders Ordinarily like to see the green shoe go a bit more quickly on solid offering, but it's Holiday weeks/seasonal very long $OCUL"""
2020-12-28,"b'$OCUL Reason for HCW downgrade....unfortunately for HCW, smart mgmt teams avoid having HCW involved in their offerings. https://t.co/LExQS04XKL https://t.co/XfCjBGasVj'"
2020-12-28,b'Ocular Therapeutix Downgraded to Neutral from Buy at H.C. Wainwright $OCUL https://t.co/4Dfjt21eN5'
2020-12-28,b'The Irony of HCW report on  $OCUL today \xf0\x9f\xa4\x94\xf0\x9f\xa4\x94\xf0\x9f\xa4\x94 no price target.     \xf0\x9f\x98\xb3\xf0\x9f\xa7\x90. Yet there is literally 50-100 other companies that they cover with what I see as literally nothing in pipeline or even okay data - but yet pretty generous price targets I see - ole well there loss https://t.co/X5aTNFJTwg'
2020-12-28,b'RT @semodough: 2020 incredible years for investors in both   $OCUL $TGTX  - into 2021 - which small caps will be 2021 big winners   -pipeli\xe2\x80\xa6'
2020-12-28,b'RT @semodough: @tun10 $OCUL AMD product most likely makes $KALA obsolete down the road'
2020-12-28,b'Recent $OCUL technical alerts: Calm After Storm... https://t.co/nzepWqtn3v'
2020-12-28,b'The Top Downgrades on FinViz Today are: $CNSP $OCUL'
2020-12-28,b'Analyst comments:  \n\n$OCUL -2.9% (downgraded to Neutral from Buy at H.C. Wainwright) \n\n$CNSP -2.8% (downgraded to Neutral from Buy at Ladenburg Thalmann)'
2020-12-28,b'@buysidebio Thanks again for $OCUL postings ...been looking @ $KALA \xe2\x80\x94is there a wart there I\xe2\x80\x99m not seeing ? Fda approved treatment and $400m mc?'
2020-12-28,"b'RT @BioStocks: $OCUL Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares.\n558,750 shares at $21.50'"
2020-12-28,b'$OCUL Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares | Business Wire\nhttps://t.co/GAzseNvD0f'
2020-12-28,b'Upgrades 12/28: \n.\nDowngrades 12/28: $CNSP $HMSY $OCUL $PRGX'
2020-12-28,b'$OCUL Ocular Therapeutics shares are trading lower after HC Wainwright &amp; Co downgraded the stock from Buy to Neutral.'
2020-12-28,"b""Today's downgrades - Dec 28\n\n$CNSP\n$OCUL\n\nhttps://t.co/HBW5h2xC7h\n#stocks #downgrades #investing https://t.co/bFbkKhuveX"""
2020-12-28,b'$OCUL\nOCUL Downgraded by HC Wainwright  and rating Buy \xe2\x9e\x9d Neutral\nSource:https://t.co/cLuXiVHuP1\n\n$ON\nON Target Raised by Mizuho with price target $34.00 \xe2\x9e\x9d $36.00 and rating Buy\nSource:https://t.co/Jw9nhIhsCa... https://t.co/qufVcF1xKg'
2020-12-28,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 53'
2020-12-28,b'$OCUL Strong demand as anticipated.  Going much higher IMO.  Long https://t.co/IIpMHOV7xB'
2020-12-28,b'RT @OpenOutcrier: $OCUL (-2.6% pre) Ocular TherapeutixTM Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares\n\nhttps://\xe2\x80\xa6'
2020-12-28,b'$OCUL (-2.6% pre) Ocular TherapeutixTM Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares\n\nhttps://t.co/5th8DXgjCA'
2020-12-28,b'$OCUL this was  a great swing will  be a looking  to add on dips https://t.co/k79CjgrsNQ'
2020-12-28,"b'RT @BioStocks: $OCUL Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares.\n558,750 shares at $21.50'"
2020-12-28,"b'$OCUL Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares.\n558,750 shares at $21.50'"
2020-12-28,b'$OCUL Ocular TherapeutixTM Announces Exercise of Underwriters\xe2\x80\x99 Option to Purchase Additional Shares\nhttps://t.co/XRFB5xqGky'
2020-12-28,"b'$HJLI 12$ target \xf0\x9f\x8e\xaf, strong buy after FDA approval $XBI $IBB $MYOV $BTC $PFE $NVAX $MRNA $OCUL $ONCT $KPTI $SPY'"
2020-12-28,b'RT @quant_data: HC Wainwright &amp; Co. Downgrades Ocular Therapeutix to Neutral\n\nRelated Tickers: $OCUL\nRead more at: https://t.co/6PBoSgJI2R'
2020-12-28,b'$OCUL  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 34'
2020-12-28,b'HC Wainwright &amp; Co. Downgrades Ocular Therapeutix to Neutral\n\nRelated Tickers: $OCUL\nRead more at: https://t.co/6PBoSgJI2R'
2020-12-28,b'$OCUL downgraded to Neutral from Buy at H.C.W'
2020-12-28,b'$OCUL: H.C. Wainwright cuts to Neutral'
2020-12-28,b'$OCUL HCW d/g to Neutral'
2020-12-28,b'Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright\n$OCUL'
2020-12-28,b'RT @buysidebio: Piper has $OCUL at almost $2B in peak cash flow. $ALC did 600M in cash flow this year and is valued at 31B. $OCUL PT raised\xe2\x80\xa6'
2020-12-28,b'@RichardMoglen $nari ans $ocul look good here.'
2020-12-28,b'@caleb_investTML @RichardMoglen Not surprised by $PTON / $GRWG ... but $OCUL on that list definitely surprised me. \xf0\x9f\xa4\xa9'
2020-12-28,b'RT @Pharmdca: @MadmastH $PAVM $KPTI $MREO $ONCT $MYOV $TRIL $OCUL $BTAI and several others\n\n$DCTH speculative at the moment'
2020-12-28,b'@MadmastH $PAVM $KPTI $MREO $ONCT $MYOV $TRIL $OCUL $BTAI and several others\n\n$DCTH speculative at the moment'
2020-12-27,"b""RT @Pharmdca: There's always opportunities in beaten down stocks that really underperformed most of the year but often these stocks (select\xe2\x80\xa6"""
2020-12-27,"b""RT @Pharmdca: There's always opportunities in beaten down stocks that really underperformed most of the year but often these stocks (select\xe2\x80\xa6"""
2020-12-27,"b""There's always opportunities in beaten down stocks that really underperformed most of the year but often these stocks (selective ones) perform well into following year but if the underlying story is well intact. $PSNL $TRIL $OCUL  few that underperformed in 2019 but on \xf0\x9f\x94\xa5 in 2020"""
2020-12-27,b'RT @semodough: 2020 incredible years for investors in both   $OCUL $TGTX  - into 2021 - which small caps will be 2021 big winners   -pipeli\xe2\x80\xa6'
2020-12-27,"b""#2021picks $IDRA $RGLS $ITRM $ALKS $OCUL $SGMO $VSTM $SMMT $INVA $ACAD #2021stockpicks ! Known all of them that's why but I bought after a a longggg research is the key !! https://t.co/GSlfBA5rL9"""
2021-01-08,"b'Ocular Therapeutix\xe2\x84\xa2 Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development $OCUL https://t.co/qXXnvUX0kg'"
2021-01-08,"b'$OCUL Ocular Therapeutix\xe2\x84\xa2 Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development https://t.co/mfTgcad3bV'"
2021-01-08,b'RT @tradertimes1: Today \nSold 1/3 position $pacb (178% gain)\nSold 1/3 position $crsp (140% gain) \nSold 1/3 position $fate (102% gain) \n\nRe-\xe2\x80\xa6'
2021-01-08,b'Today \nSold 1/3 position $pacb (178% gain)\nSold 1/3 position $crsp (140% gain) \nSold 1/3 position $fate (102% gain) \n\nRe-started 1/2 position $blue (tax loss last year for me)\n\nStarted 1/2 position $IPOE\n\nAdded $adap $psnl \n\n$tdoc $ocul remain by far my largest positions'
2021-01-08,"b""@jablamsky Yep, I've sold off biotechs on a dip only to see them green a few weeks (or hours) later.  I've also bought into a few that stayed down. I have learned that sometimes they need time to recover. I also find buying in after a secondary has been productive. $OCUl was a good example."""
2021-01-08,b'RT @buysidebio: I would guess gene therapy applications are coming soon for $OCUL on top of someone overseeing TKI. Great hire by them'
2021-01-07,b'RT @buysidebio: I would guess gene therapy applications are coming soon for $OCUL on top of someone overseeing TKI. Great hire by them'
2021-01-07,b'I would guess gene therapy applications are coming soon for $OCUL on top of someone overseeing TKI. Great hire by them https://t.co/A7UoUFWT6v'
2021-01-07,b'@Pharmdca $OCUL'
2021-01-07,"b'@Phoenix3million $OCUL has cyclosporine for long treatment, which are quite ineffective so short term flare ups will still need to be controlled (same as restasis). And I dont see the point of steroid inserts (ph I) as these are for short term treatment only. Who is gonna get an insert for 2wks?'"
2021-01-07,"b'$OCUL I believe that there are very few free shares left on the market, .. the first big news will make us take the big leap (IMHO)'"
2021-01-07,"b""Rose Above Previous Day's High today: $GH $SAGE $ADPT $LGND $KRTX $YMAB $OCUL $TBIO $XLRN $PODD $DNLI $COMM $GXGX $STNG $ING $FUBO $AVTR $BX $ARKK $NJR ... https://t.co/TBYRpvrFqi"""
2021-01-07,"b'Nice to see the pick of the week #3 $EYPT finally be in the green. I\xe2\x80\x99m considering doing an episode re-hashing all these ophthalmology companies $OCUL, $KALA. What else should I look at?'"
2021-01-07,"b""$EYPT is literally $OCUL in a horrible cash position and no pipeline in DED and glaucoma.\n\nBut also trades 10X cheaper.\n\nInteresting to note $EYPT's EYP-1901 is not behind $OCUL's OTX-TKI in the US. Will probably even beat them to the punch on a topline data readout."""
2021-01-07,b'RT @buysidebio: $OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out manageme\xe2\x80\xa6'
2021-01-07,"b'$OCUL: Ocular Therapeutix promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and appoints Rabia Gurses... https://t.co/YJTXejjKTY'"
2021-01-07,"b'RT @sentivcapital: $OCUL Extremely bullish sign for pipeline, esp Feb readout on TKI 600 dose. Expanding your clinical team with a highly d\xe2\x80\xa6'"
2021-01-07,b'RT @buysidebio: $OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out manageme\xe2\x80\xa6'
2021-01-07,b'RT @buysidebio: $OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out manageme\xe2\x80\xa6'
2021-01-07,b'Feel like $OCUL has injected new energy into eye space in spite of potential acquirers dwindling. ($AGN gone). cc @sentivcapital'
2021-01-07,"b'RT @sentivcapital: $OCUL Extremely bullish sign for pipeline, esp Feb readout on TKI 600 dose. Expanding your clinical team with a highly d\xe2\x80\xa6'"
2021-01-07,"b'RT @sentivcapital: $OCUL Extremely bullish sign for pipeline, esp Feb readout on TKI 600 dose. Expanding your clinical team with a highly d\xe2\x80\xa6'"
2021-01-07,"b'RT @sentivcapital: $OCUL Extremely bullish sign for pipeline, esp Feb readout on TKI 600 dose. Expanding your clinical team with a highly d\xe2\x80\xa6'"
2021-01-07,b'RT @buysidebio: $OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out manageme\xe2\x80\xa6'
2021-01-07,"b""$OCUL Extremely bullish sign for pipeline, esp Feb readout on TKI 600 dose. Expanding your clinical team with a highly desired hire usually means good things are happening under the hood. Ignore now, cry later. Meanwhile, congrats to Mike, couldn't have happened to a nicer guy. https://t.co/5bBvPo0RgP"""
2021-01-07,b'Today\xe2\x80\x99s LONG Watchlist:\n\n$DAL $OCUL $RBBN $RCKT $SOLO $UBER https://t.co/CouuY1y3VQ'
2021-01-07,b'RT @buysidebio: $OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out manageme\xe2\x80\xa6'
2021-01-07,b'RT @buysidebio: $OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out manageme\xe2\x80\xa6'
2021-01-07,b'$OCUL brings on Former CMO of nightstar therapeutics. Pretty bullish on TKI and what $OCUL is seeing to expand out management. Great hire. https://t.co/0tcL7MT3JR'
2021-01-07,"b'RT @semodough: $OCUL Ocular Therapeutix\xe2\x84\xa2 Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden,\xe2\x80\xa6'"
2021-01-07,"b'$OCUL Ocular Therapeutix\xe2\x84\xa2 Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development | Ocular Therapeutix, Inc. https://t.co/0PHFD42BW5'"
2021-01-07,"b'$OCUL [15s. delayed]: Issued Press Release on January 07, 08:00:00: Ocular Therapeutix\xe2\x84\xa2 Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development https://t.co/CtTb8RdjZ8'"
2021-01-07,"b'$OCUL Ocular Therapeutix\xe2\x84\xa2 Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development \nhttps://t.co/PH9HHIrT63'"
2021-01-07,"b""Congrats to $KALA on the launch of Eysuvis. It's the launch I am watching the closest. Will be challenging, but good mgmt team. Interesting to see a TKI for wAMD being added to (preclinical) pipeline. -&gt; $OCUL $GRAY $EYPT"""
2021-01-07,b'RT @EvanMedeiros: Ocular consolidating nicely after a 160% rip over 6 weeks. Give it some time to settle in and recharge. Discussed this $O\xe2\x80\xa6'
2021-01-06,"b""Ocular consolidating nicely after a 160% rip over 6 weeks. Give it some time to settle in and recharge. Discussed this $OCUL chart along with $WIX $FLNT $SRPT $EVBG $OKTA in today's trade video:  https://t.co/T4j7MWQrqW  #Stocks #Trading https://t.co/AFbGVqBQhK"""
2021-01-06,b'RT @EvanMedeiros: NEW VIDEO: Stock market swing trade ideas for your watchlist https://t.co/7IHIrmDHXr  $OCUL $WIX $FLNT $SRPT $EVBG $OKTA\xe2\x80\xa6'
2021-01-06,b'whoever is putting the $0 perma bid on my $OCUL calls is such a cheese dick'
2021-01-06,b'PROGRESS: $OCUL\nRebound around 20\xf0\x9f\x98\x98 https://t.co/loOhtJfCpW'
